ATR President Grover Norquist has released a letter to the House Armed Services Committee urging lawmakers to reject any “Buy American” amendments to the FY 2021 National Defense Authorization Act (NDAA). 

Some lawmakers are using the COVID-19 pandemic as an excuse to push Buy American mandates, which would place unnecessary sourcing requirements on medicines and medical inputs purchased with federal dollars. 

If implemented, Buy American mandates will disrupt the medical supply chain, threatening timely access to medicines and leading to retaliatory actions from trading partners. During this unprecedented health crisis, a Buy American policy could even threaten our ability to adequately respond to the pandemic.

Click here to read the full letter.